A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
To compile characteristics of real-world clinical outcomes for Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice, when used according to the applicable Instructions for Use
- and -
To evaluate the economic value and technical performance of Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice
The study is a prospective, multi-center, global, post-market study of Boston Scientific neurostimulation systems for pain.
The study treatment will consist of neurostimulation trial therapy with any commercially approved Boston Scientific Corporation neurostimulator for pain. Positive trials, subjects with a successful trial outcome, may progress to permanent implant of a neurostimulation system. Individualization of neurostimulation therapy for pain will be determined according to investigator discretion and site routine care, and in accordance with inclusion and exclusion criteria.
Key Inclusion Criteria:
Key Exclusion Criteria:
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
Miami Gardens, Florida 33169, United States
Chicago, Illinois 60611, United States
Evansville, Indiana 47714, United States
Shreveport, Louisiana 71105, United States
Nishinomiya-shi, Japan
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890
BSNClinicalTrials@bsci.com855-213-9890